Konapharma is a privately owned Swiss CMO (Contract Manufacturing Organization). A member of Rhenopharma Group together with allpack ag, Kona is focused on the production of solid dosage forms, specialized in MUPS (Multi unit pellet systems), tablets and other retard forms. Kona also holds a special permit to handle and process controlled substances like narcotics and offers a proprietary long acting Methylphenidate formulation.
In blistering and packaging Konapharma offers high volume blistering but also “difficult to pack” services for special packaging needs, e.g. inhalation capsules.